Adolor down on failed Entereg trial

ADLR was off $7.41 (46%) to $8.78 on 18.9 million shares on Thursday after its Entereg alvimopan missed

Read the full 188 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE